HOME >> MEDICINE >> NEWS
Researchers at Cincinnati Children's link a strain of E. coli to diarrhea in children

SAN FRANCISCO Researchers at Cincinnati Children's Hospital Medical Center have determined that a bacterium called enteroaggregative E. coli, is responsible for 10 percent of cases of diarrhea in children. The discovery could one day lead to new treatment for children who suffer from diarrhea.

A number of strains of E. coli have been linked to diarrhea, but this is the first time that enteroaggregative E. coli has been linked to the illness in the United States. One of the most important aspects of the new study was the use of genetic technology to look for the presence of specific patterns of E. coli DNA. This in turn led to the identification of genes associated with diarrhea.

Other tests that look for E. coli infections are based on the use of tissue culture cells, which is not always a reliable way to identify specific strains of E. coli, according to Mitchell B. Cohen, M.D., a professor of pediatrics at Cincinnati Children's who led the research team.

Once confirmed in follow-up studies, the new research could eventually lead to the availability of testing for enteroaggregative E. coli, he said.

"The lack of having a test is, in part, why medical professionals have never really before linked enteroaggregative E. coli to diarrhea in children in the United States," Dr. Cohen said. "The identification of a different etiology allows us to focus on the question of whether diarrhea caused by viruses or bacteria should be treated differently. The strength of the study is that we can now look at these children and decide if we should develop therapies to target bacterial or viral infections."

Mary A. Staat, M.D, M.P.H., an associate professor of infectious diseases and study co-author, will present the results of the study on May 2 in San Francisco at the annual meeting of the Pediatric Academic Societies.

E. coli is a foodborne pathogen and a bacterium that normally resides in the lower intestine. There are hundreds o
'"/>

Contact: Amy Reyes
amy.reyes@cchmc.org
513-636-9684
Cincinnati Children's Hospital Medical Center
2-May-2004


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...
(Date:5/23/2013)... Spring and summer have always been motivation for people ... the city between Memphis and Nashville? In the last year ... has transformed the growing area into one of the most ... of vibrant, young professionals you are going to see demand ... owner of The Fight Shop, one of the city’s hottest ...
(Date:5/23/2013)... Concert Tickets announces that Paul McCartney will be ... America. This well known ticket website has slashed prices ... McCartney fans see Sir Paul live in concert. Jan, ... also offering the customer appreciation code SAVE for additional savings ... is also a huge McCartney fan and plans to see ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Teen birth rates in ... according to a new government report. Overall, the rate ... nearly one half from 1991 to 2011 -- from about ... every 1,000. From 2007 to 2011, the most recent ... about 31. During that time, rates fell at least ...
(Date:5/23/2013)... that an immune regulatory molecule called IL-21 is needed ... , The results are published in the Journal ... could be important in the development of antiviral vaccines," ... first author of the paper. The senior author is ... and a Georgia Research Alliance Eminent Scholar. , The ...
Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
(Date:5/23/2013)... and PARIS , May ... ), a leading developer and manufacturer of precision guided ... of coronary and peripheral vascular disease, today announced preliminary ... asodilator I ndependent S tenosis E ... clinical trial session at EuroPCR 2013. These prospective results ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
Cached News: